Cargando…

Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States

This study is a 6-month retrospective analysis of urine drug testing (UDT) data from a pain management population among specimens with clinician-ordered marijuana testing (N = 194 809). Descriptive statistics about the specimen positivity of clinician-ordered marijuana UDT are provided as well as ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Smiley-McDonald, Hope M, Moore, Katherine N, Heller, David C, Ropero-Miller, Jeri D, McIntire, Gregory L, Wallace, Frank N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562347/
https://www.ncbi.nlm.nih.gov/pubmed/29104427
http://dx.doi.org/10.1177/1178221817724783
_version_ 1783257956840636416
author Smiley-McDonald, Hope M
Moore, Katherine N
Heller, David C
Ropero-Miller, Jeri D
McIntire, Gregory L
Wallace, Frank N
author_facet Smiley-McDonald, Hope M
Moore, Katherine N
Heller, David C
Ropero-Miller, Jeri D
McIntire, Gregory L
Wallace, Frank N
author_sort Smiley-McDonald, Hope M
collection PubMed
description This study is a 6-month retrospective analysis of urine drug testing (UDT) data from a pain management population among specimens with clinician-ordered marijuana testing (N = 194 809). Descriptive statistics about the specimen positivity of clinician-ordered marijuana UDT are provided as well as other drug positivity. Specimens from men and adults aged 18 to 34 years had the highest prevalence rates of marijuana positivity. The prevalence of past-month marijuana use among a comparative national population was lower than the prevalence of positive marijuana tests in the UDT specimens by all characteristics. Among the specimens tested for illicit drugs and marijuana, 4.0% were positive for amphetamine, 2.8% were positive for cocaine, and 0.9% were positive for heroin. The most common prescription drugs listed were opioids (64.7%), benzodiazepines (20.5%), and antidepressants (19.9%). In sum, the findings reflect previous research showing high rates of marijuana use, illicit drug use, and prescription drug use in a pain management population.
format Online
Article
Text
id pubmed-5562347
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55623472017-11-02 Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States Smiley-McDonald, Hope M Moore, Katherine N Heller, David C Ropero-Miller, Jeri D McIntire, Gregory L Wallace, Frank N Subst Abuse Review This study is a 6-month retrospective analysis of urine drug testing (UDT) data from a pain management population among specimens with clinician-ordered marijuana testing (N = 194 809). Descriptive statistics about the specimen positivity of clinician-ordered marijuana UDT are provided as well as other drug positivity. Specimens from men and adults aged 18 to 34 years had the highest prevalence rates of marijuana positivity. The prevalence of past-month marijuana use among a comparative national population was lower than the prevalence of positive marijuana tests in the UDT specimens by all characteristics. Among the specimens tested for illicit drugs and marijuana, 4.0% were positive for amphetamine, 2.8% were positive for cocaine, and 0.9% were positive for heroin. The most common prescription drugs listed were opioids (64.7%), benzodiazepines (20.5%), and antidepressants (19.9%). In sum, the findings reflect previous research showing high rates of marijuana use, illicit drug use, and prescription drug use in a pain management population. SAGE Publications 2017-08-16 /pmc/articles/PMC5562347/ /pubmed/29104427 http://dx.doi.org/10.1177/1178221817724783 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Smiley-McDonald, Hope M
Moore, Katherine N
Heller, David C
Ropero-Miller, Jeri D
McIntire, Gregory L
Wallace, Frank N
Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title_full Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title_fullStr Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title_full_unstemmed Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title_short Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States
title_sort patterns of marijuana use in a 6-month pain management sample in the united states
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562347/
https://www.ncbi.nlm.nih.gov/pubmed/29104427
http://dx.doi.org/10.1177/1178221817724783
work_keys_str_mv AT smileymcdonaldhopem patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates
AT moorekatherinen patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates
AT hellerdavidc patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates
AT roperomillerjerid patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates
AT mcintiregregoryl patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates
AT wallacefrankn patternsofmarijuanauseina6monthpainmanagementsampleintheunitedstates